Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study-Reference-Cited by-同舟云学术

Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study

Published:2020-09 Issue:3 Volume:158 Page:562-569
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Huh Warner K.,Brady William E.,Fracasso Paula M.,Dizon Don S.,Powell Matthew A.,Monk Bradley J.,Leath Charles A.,Landrum Lisa M.,Tanner Edward J.,Crane Erin K.,Ueda Stefanie,McHale Michael T.,Aghajanian Carol

Funder

NCI

Bristol Myers Squibb

Kazia

Tesaro

Lilly

Advasix

Genentech

NIH

Agenus

Clovis

AbbVie

AstraZeneca

National Institute of Health

NRG Operations

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference27 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

2. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States;Wheeler;J. Natl. Cancer Inst.,2009

3. Improved survival with bevacizumab in advanced cervical cancer;Tewari;N. Engl. J. Med.,2014

4. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study;Monk;J. Clin. Oncol.,2009

5. Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240);Tewari;Lancet,2017

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacotherapy for cervical cancer: current standard of care and new perspectives;Expert Opinion on Pharmacotherapy;2024-08-12

2. Cancer immunotherapy and its facilitation by nanomedicine;Biomarker Research;2024-08-03

3. GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 trial;eClinicalMedicine;2024-08

4. New Frontiers in Locally Advanced Cervical Cancer Treatment;Journal of Clinical Medicine;2024-07-30

5. Understanding the HPV associated cancers: A comprehensive review;Molecular Biology Reports;2024-06-14